Calquence is under clinical development by AstraZeneca and currently in Phase II for Primary Mediastinal B-Cell Lymphoma.

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Neuroendocrine Tumors.

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug ...

HMWK Ready to use 34 βE12 Novocastra, New Castle, UK EMA Ready to use GP1.4 Novocastra, New Castle, UK CK Ready to use AE1/AE3 Novocastra, New Castle, UK CK20 Ready to use PW31 Novocastra, New ...

In a recent study published in Nature, researchers from Washington University investigated how dietary fructose indirectly promotes tumor growth through metabolic mechanisms involving the liver.

High-fructose corn syrup, a sweetener made from corn starch, is widely found in common foods. Due to its widespread use, the consumption of fructose has increased over the past five decades.

Instead, WashU scientists discovered that the liver converts fructose into usable nutrients for cancer cells, a compelling finding that could open up new avenues for care and treatment of many ...

Specially packaged DNA secreted by tumor cells can trigger an immune response that inhibits the metastatic spread of the tumor to the liver, according to a study led by researchers at Weill ...

According to Oxford University Press, which publishes the Oxford English Dictionary (OED), the term “brain rot” is defined as the “supposed deterioration of a person’s mental or ...